Controversial board move doesn’t stop StemCells from raising $20 million
San Francisco Business Times (blog)
In the offering, StemCells will sell nearly 11.3 million shares of common stock as well as short-term warrants for the purchase of more than 9.6 million additional shares. The stock and warrants will be sold as units of one share of stock and a warrant …
StemCells, Inc. Announces Proposed $20 Million OfferingMarketWatch
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.